intracerebral%20hemorrhage
INTRACEREBRAL HEMORRHAGE
Intracerebral hemorrhage is the sudden burst of blood into the brain tissue itself.
It causes sudden onset of focal neurological deficit.
The focal neurologic findings are related to the anatomic location, size and speed of development of intracerebral hemorrhage.
Neurological deficit usually progresses over a minute to an hour.
Rapid recognition and diagnosis of intracerebral hemorrhage are essential because of its frequently rapid progression.

Intracerebral Hemorrhage Drug Information

Drug Information

Indication: BP control in acute hypotensive states eg, pheochromocytomectomy, sympathectomy, poliomyelitis, spinal anaesth...

Indication: HTN. Adjunct to digitalis &/or diuretic therapy in CHF.

Dosage: Essential HTN Initially 10-20 mg daily. Maintenance: 20 mg once daily. Max: 40 mg daily. Renovascular HTN Init

Indication: BP control in acute hypotensive states. Adjunctive treatment in cardiac arrest & profound hypotension.

Indication: Severe HTN in pregnancy. Hypotensive anaesth. Hypertensive episodes following acute MI.

Indication: All grades of essential HTN. Renovascular HTN. All degrees of heart failure. Prevention of symptomatic heart f...

Dosage: Tab Mild, moderate or severe HTN & angina pectoris w/ coexisting HTN Initially 100 mg bd. Increase in dose

1  /  3
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
29 Mar 2020
Targeting a low-density lipoprotein cholesterol level <70 mg/dL following an ischaemic stroke of atherosclerotic origin helps to avoid one in four subsequent major vascular events without increasing the risk of intracranial haemorrhage over about 5 years of follow-up, according to data from the Treat Stroke to Target trial.
Pearl Toh, 12 Sep 2020
Early initiation of rhythm-control therapy led to a significantly reduced risk of major adverse cardiovascular (CV) outcomes compared with usual care (typically rate control) in patients with newly diagnosed atrial fibrillation (AF) at risk of stroke, reveals the EAST-AFNET 4* trial presented at ESC 2020.
Audrey Abella, 16 Sep 2020
The final results of EVAPORATE* reinforce the plaque-regressing potential of icosapent ethyl (IPE) in patients on statins for elevated triglycerides.
01 Feb 2020
High-intensity statin therapy appears to be seeing increased use in patients with acute coronary syndrome and leads to better lipid control, according to a recent Thailand study.